These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 848312)

  • 21. [Synthesis of 1,3,5-triazacycloheptane derivatives. I. Synthesis of alkyl and aryl derivatives of ethylenediamine].
    Strumillo J
    Acta Pol Pharm; 1976; 33(5):565-70. PubMed ID: 998306
    [No Abstract]   [Full Text] [Related]  

  • 22. Biochemical, morphochemical and pharmacodynamic evaluation of accumulation of ethylenediamine derivatives (ROM-203, MK-142) in some rat tissues.
    Noyszewska-Skibińska I; Nowicka A; Ernest K; Nowicka J
    Mater Med Pol; 1977; 9(3):216-24. PubMed ID: 926836
    [No Abstract]   [Full Text] [Related]  

  • 23. N,N'-bis(S-benzoylmercaptoacetamido) ethylenediamine and propylenediamine ligands as renal function imaging agents. I. Alternate synthetic methods.
    Schneider RF; Subramanian G; Feld TA; McAfee JG; Zapf-Longo C; Palladino E; Thomas FD
    J Nucl Med; 1984 Feb; 25(2):223-9. PubMed ID: 6427431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct assay of conjugates of penbutolol and its metabolites in urine.
    Lehr KH; Damm P; Hajdù P
    Arzneimittelforschung; 1987 Dec; 37(12):1373-5. PubMed ID: 3449064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Peculiarities in the distribution of oxacillin and some of its derivatives in the body].
    Vasil'ev VK; Navashin SM
    Antibiotiki; 1967 Jul; 12(7):596-602. PubMed ID: 5595921
    [No Abstract]   [Full Text] [Related]  

  • 26. [New method for the volumetric determination of ethylenediamine].
    DE LORENZI F
    Boll Chim Farm; 1955 Sep; 94(9):343-5. PubMed ID: 13284114
    [No Abstract]   [Full Text] [Related]  

  • 27. Chromous chloride reduction. 8. Reaction of some derivatives and degradation products of heptachlor with chromous chloride-ethylenediamine complex and nuclear magnetic resonance and mass spectra of the products.
    Chau AS; Demayo A; ApSimon JW; Buccini JA; Fruchier A
    J Assoc Off Anal Chem; 1974 Jan; 57(1):205-16. PubMed ID: 4814320
    [No Abstract]   [Full Text] [Related]  

  • 28. [Quantitative determination of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethylenediamine dihydrochloride (Falirytmin) in blood].
    Pönicke K; Hauer I; Sziegoleit W; Förster W
    Pharmazie; 1976; 31(9):613-4. PubMed ID: 1019208
    [No Abstract]   [Full Text] [Related]  

  • 29. Stability study of aminophylline suppositories. Part I: Decomposition products and specific assay method for ethylenediamine.
    van Dop C; Overvliet GM; Smits HM
    Pharm Acta Helv; 1981; 56(9-10):281-4. PubMed ID: 7291212
    [No Abstract]   [Full Text] [Related]  

  • 30. [Stability of imidazoline derivatives. V. Determination of thimazoline hydrochloride and N-(2-thymoloxyacetyl)ethylenediamine in mixtures].
    Grabowska I; Kraczkowska A
    Acta Pol Pharm; 1981; 38(6):701-4. PubMed ID: 7348530
    [No Abstract]   [Full Text] [Related]  

  • 31. Determination of dl-fencamine in rat and human urine.
    Mallol J; Pitarch L; Coronas R; Pons A
    Arzneimittelforschung; 1974 Sep; 24(9):1301-4. PubMed ID: 4154765
    [No Abstract]   [Full Text] [Related]  

  • 32. [Stereochemistry of 1-aryl-2-isopropylaminopropan-1-ols. N.M.R. spectra and ionization constants].
    Villa L; Taddei F; Schenetti L; Ferri V
    Farmaco Sci; 1974 Feb; 29(2):159-66. PubMed ID: 4426381
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biotransformation and excretion of N,N'-bis(3-(2-ethoxyphenoxy)-2-hydroxypropyl)ethylenediamine dihydrochloride (Falirytmin) in rats].
    Pfeifer S; Plonka GR; Dobbrodt I; Franke P; Steenbeck L
    Pharmazie; 1990 Oct; 45(10):751-5. PubMed ID: 2128542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hydroxylation and thin layer chromatographic separation of main and secondary components of Brevicid].
    Zarnack J; Tönjes H; Pötter H
    Pharmazie; 1971 Aug; 26(8):503-4. PubMed ID: 5122941
    [No Abstract]   [Full Text] [Related]  

  • 35. [Quantitative determination of N,N-bis[3-2'-ethoxyphenoxy)-2-hydroxypropyl]ethylenediamine dihydrochloride (Falirytmin) in plasma].
    Wellner K; Herzberg H; Neubert R; Fürst W; Napiontek B
    Pharmazie; 1990 May; 45(5):372-3. PubMed ID: 2395902
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biotransformation, distribution and excretion of glycilanesthesine in rats].
    Pachecka J; Słojkowska Z
    Acta Pol Pharm; 1981; 38(6):723-9. PubMed ID: 7348533
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intracellular identification of cardiac drugs by means of electron-microscopic autoradiography].
    Löhr E; Göbbeler T; Makoski HB; Popitz G
    Arzneimittelforschung; 1974 Nov; 24(11):1733-41. PubMed ID: 4480044
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmaceutical chemical and analytical data for the pharmaceutically-active substance carteolol hydrochloride].
    Winkler W
    Arzneimittelforschung; 1983; 33(2a):279-80. PubMed ID: 6682318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits.
    Andermann G; Guggenbuhl P; de Burlet G; Himber J
    Methods Find Exp Clin Pharmacol; 1989 Dec; 11(12):747-54. PubMed ID: 2576299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electronic properties of N-heteroaromatics. XII. On the mode of interaction between theophylline and ethylenediamine in aqueous solution.
    Okano T; Aita K; Ikeda K
    Chem Pharm Bull (Tokyo); 1967 Nov; 15(11):1621-5. PubMed ID: 5583816
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.